Does risk exist in severe burned patients applied with recombinant growth hormone? / 中华临床营养杂志

Effectiveness of recombinant human growth hormone ( rhGH) in treating critically ill or severe burned patients have been demonstrated. Although adverse effects of rhGH have also been identified, they are controllable. The dosage and timing of rhGH must be well designed, and hyperglycemia be controlled. Application of rhGH in critically ill patients should be deliberately considered.